Anebulo Pharmaceuticals, Inc.

10-Q Quarter ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Delisting notice or listing-rule failure; Other events Feb 6, 2026 8-K Other events Jan 29, 2026 8-K Other events Jan 27, 2026 8-K Other events Dec 22, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-K Fiscal year ended 2025-06-30 Sep 29, 2025 8-K Results of operations (earnings release) Sep 29, 2025 8-K Other events Sep 12, 2025 8-K Other events Jul 23, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Other events Apr 15, 2025 8-K Amended charter or bylaws Apr 14, 2025 8-K Director or officer change; Shareholder vote results Apr 7, 2025 8-K Entered a material agreement; Delisting notice or listing-rule failure Feb 24, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Results of operations (earnings release) Feb 14, 2025 8-K Other events Feb 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Other events Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Regulation FD disclosure Oct 17, 2024 10-K Fiscal year ended 2024-06-30 Sep 25, 2024 8-K Results of operations (earnings release) Sep 25, 2024 8-K Other events Jul 22, 2024 8-K Other events Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2023-12-31 Feb 13, 2024 8-K Results of operations (earnings release) Feb 13, 2024 8-K Shareholder vote results Nov 21, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Nov 14, 2023 8-K Director or officer change Oct 6, 2023 8-K Director or officer change Sep 29, 2023 10-K Fiscal year ended 2023-06-30 Sep 22, 2023 8-K Results of operations (earnings release) Sep 20, 2023